CRSP icon

CRISPR Therapeutics

442 hedge funds and large institutions have $5.19B invested in CRISPR Therapeutics in 2021 Q1 according to their latest regulatory filings, with 107 funds opening new positions, 175 increasing their positions, 95 reducing their positions, and 71 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

less call options, than puts

Call options by funds: $ | Put options by funds: $

9.32% less ownership

Funds ownership: 66.31%56.99% (-9.3%)

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

28% less capital invested

Capital invested by funds: $7.23B → $5.19B (-$2.04B)

Holders
442
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$360M
Puts
$396M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.01B
2
$593M
3
$446M
4
$194M
5
$189M
6
$158M
7
$157M
8
$139M
9
$131M
10
$125M
11
$119M
12
$112M
13
$106M
14
$101M
15
$71.5M
16
$69.2M
17
$67.8M
18
$67.3M
19
$67.1M
20
$56.8M
21
$54.7M
22
$46.3M
23
$45.9M
24
$45.3M
25
$44.5M